WO2007054976A3 - Lipid based controlled release pharmaceutical composition - Google Patents
Lipid based controlled release pharmaceutical composition Download PDFInfo
- Publication number
- WO2007054976A3 WO2007054976A3 PCT/IN2006/000438 IN2006000438W WO2007054976A3 WO 2007054976 A3 WO2007054976 A3 WO 2007054976A3 IN 2006000438 W IN2006000438 W IN 2006000438W WO 2007054976 A3 WO2007054976 A3 WO 2007054976A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- controlled release
- release pharmaceutical
- pharmaceutical composition
- lipid based
- based controlled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Abstract
Novel controlled release pharmaceutical compositions are provided which release the active agent(s) over an extended period of time comprising a core wherein the said core comprises at least one active agent(s) which is preferably water soluble, a lipid system comprising at least one lipid component(s), at least one water insoluble release modifier(s), at least one channel forming agent(s) and optionally one or more pharmaceutically acceptable excipients; and at least one coat. Preferably the coating composition comprises at least one hydrophilic pH independent polymer(s) and optionally one or more pharmaceutically acceptable excipients. Also provided is a process of preparation of such compositions and method of using them.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2985DE2005 | 2005-11-08 | ||
IN2985DEL/2005 | 2005-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007054976A2 WO2007054976A2 (en) | 2007-05-18 |
WO2007054976A3 true WO2007054976A3 (en) | 2007-08-09 |
Family
ID=38023688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2006/000438 WO2007054976A2 (en) | 2005-11-08 | 2006-11-07 | Lipid based controlled release pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007054976A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8377977B2 (en) | 2004-08-13 | 2013-02-19 | Boehringer Ingelheim International Gmbh | Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
US8637540B2 (en) | 2003-11-26 | 2014-01-28 | Acura Pharmaceuticals | Compositions for deterring abuse of opioid containing dosage forms |
US8715728B2 (en) | 2004-08-13 | 2014-05-06 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
US8901113B2 (en) | 2009-09-30 | 2014-12-02 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
US9101636B2 (en) | 2012-11-30 | 2015-08-11 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050226926A1 (en) | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
WO2007090882A2 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical extended release compositions comprising pramipexole |
US20100143471A1 (en) * | 2007-03-21 | 2010-06-10 | Lupin Limited | Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine |
CA2684550A1 (en) * | 2007-04-24 | 2008-10-30 | Boehringer Ingelheim International Gmbh | Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
WO2010083360A2 (en) * | 2009-01-16 | 2010-07-22 | Mutual Pharmaceutical Company, Inc. | Controlled-release formulations |
US20100297195A1 (en) * | 2009-05-20 | 2010-11-25 | Ranbaxy Laboratories Limited | Controlled release lamotrigine formulations |
TR200905670A1 (en) * | 2009-07-22 | 2011-02-21 | Sanovel �La� San.Ve T�C.A.�. | Levetiracetam pharmaceutical compositions for prolonged release |
TR201001862A1 (en) * | 2010-03-11 | 2011-10-21 | Sanovel �La� San.Ve T�C.A.�. | Controlled release pramipexole formulations. |
EP2380560A1 (en) * | 2010-04-22 | 2011-10-26 | ratiopharm GmbH | Matrix tablets containing pramipexol |
KR101307334B1 (en) * | 2010-07-02 | 2013-09-12 | 주식회사 바이오파마티스 | Sustained-release pharmaceutical composition comprising pramipexole or pharmaceutically acceptable salt thereof having improved stability |
WO2013058409A1 (en) | 2011-10-21 | 2013-04-25 | Takeda Pharmaceutical Company Limited | Sustained-release preparation |
CN104367562A (en) * | 2013-08-15 | 2015-02-25 | 上海星泰医药科技有限公司 | Pramipexole dihydrochloride slow-release tablets and preparation method thereof |
US20190000126A1 (en) * | 2015-01-07 | 2019-01-03 | Corr-Jensen Inc. | Compositions and methods for enhancing athletic performance |
US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
CN109982690A (en) * | 2016-05-11 | 2019-07-05 | 雷尔玛达治疗公司 | Wear-resisting opioid formulation |
CN106727357B (en) * | 2017-01-19 | 2020-09-18 | 杭州益品新五丰药业有限公司 | Acyclovir granules and preparation method thereof |
CN109125270B (en) * | 2017-06-27 | 2021-03-19 | 广州帝奇医药技术有限公司 | Solid preparation and preparation method thereof |
WO2021033180A1 (en) * | 2019-08-16 | 2021-02-25 | Adel Penhasi | Adhesive drug delivery microparticles and a product comprising thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003063834A1 (en) * | 2002-02-01 | 2003-08-07 | Pacific Corporation | Multi-stage oral drug controlled-release system |
WO2004012699A2 (en) * | 2002-08-05 | 2004-02-12 | Torrent Pharmaceuticals Limited | Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent |
US20040062800A1 (en) * | 2000-12-20 | 2004-04-01 | Burnside Beth A. | Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
-
2006
- 2006-11-07 WO PCT/IN2006/000438 patent/WO2007054976A2/en active Search and Examination
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040062800A1 (en) * | 2000-12-20 | 2004-04-01 | Burnside Beth A. | Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
WO2003063834A1 (en) * | 2002-02-01 | 2003-08-07 | Pacific Corporation | Multi-stage oral drug controlled-release system |
WO2004012699A2 (en) * | 2002-08-05 | 2004-02-12 | Torrent Pharmaceuticals Limited | Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8637540B2 (en) | 2003-11-26 | 2014-01-28 | Acura Pharmaceuticals | Compositions for deterring abuse of opioid containing dosage forms |
US8822489B2 (en) | 2003-11-26 | 2014-09-02 | Acura Pharmaceuticals | Abuse deterrent compositions and methods of making same |
US9492443B2 (en) | 2003-11-26 | 2016-11-15 | Acura Pharmaceuticals, Inc. | Abuse deterrent compositions and methods of making same |
US8377977B2 (en) | 2004-08-13 | 2013-02-19 | Boehringer Ingelheim International Gmbh | Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
US8715728B2 (en) | 2004-08-13 | 2014-05-06 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
US8901113B2 (en) | 2009-09-30 | 2014-12-02 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
US9101636B2 (en) | 2012-11-30 | 2015-08-11 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US9320796B2 (en) | 2012-11-30 | 2016-04-26 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
Also Published As
Publication number | Publication date |
---|---|
WO2007054976A2 (en) | 2007-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007054976A3 (en) | Lipid based controlled release pharmaceutical composition | |
WO2008022932A3 (en) | Controlled release system and method for manufacturing the same | |
WO2007000778A3 (en) | Modified release pharmaceutical compositions on the basis of two polymers and processes thereof | |
TNSN08365A1 (en) | Sustained release pharmaceutical composition on the basis of release system comprising an acid-soluble polymer and a ph-dependent polymer | |
WO2006039499A3 (en) | Method for improving the biovailability of orally delivered therapeutics | |
WO2007020259A3 (en) | Controlled release pharmaceutical compositions for acid labile drugs | |
WO2008061226A3 (en) | Sustained-release formulations of topiramate | |
WO2006121941A3 (en) | Pharmaceutical compositions comprising imatinib and a release retardant | |
WO2005123134A3 (en) | A controlled release delivery system for metformin | |
WO2001052816A3 (en) | Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same | |
BR9915087A (en) | Enteric coated oral pharmaceutical formulation, use of a hydroxypropyl cellulose (hpc) quality, process for the manufacture of an enteric coated oral pharmaceutical formulation, use of a pharmaceutical formulation, and method for the treatment of gastrointestinal diseases in mammals, including man | |
WO2007086078A3 (en) | Novel pharmaceutical compositions and process of preparation thereof | |
WO2007034503A3 (en) | Controlled release dosage formulation of duloxetine | |
WO2005069933A3 (en) | Methods of treating an inflammatory-related disease | |
EP2110135A3 (en) | A pharmaceutical composition for treating depression and method for preparation thereof | |
WO2006058250A3 (en) | Orally disintegrating compositions | |
WO2010037854A3 (en) | Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules | |
WO2005079861A3 (en) | Polymeric water soluble prodrugs | |
WO2001070197A3 (en) | Method for preparing high pressure/high shear dispersions containing physiologically active ingredients | |
WO2008084698A1 (en) | Tacrolimus sustained release pharmaceutical composition | |
WO2003057150A3 (en) | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof | |
MX341015B (en) | Extended-release dosage form. | |
WO2004066984A3 (en) | Improved taste masking pharmaceutical composition and process for its preparation | |
WO2003041656A3 (en) | Soluble drug extended release system | |
WO2008023390A3 (en) | Modified release pharmaceutical composition of bupropion hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06821697 Country of ref document: EP Kind code of ref document: A2 |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |